Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. AMKS TIME RELEASE LAB, LLC
WARNING LETTER
•AMKS TIME RELEASE LAB, LLC•July 12, 2013

AMKS TIME RELEASE LAB, LLC – FDA Warning Letter, Jul 12, 2013

Record Details

The FDA issued a Warning Letter to AMKS Time Release Laboratories, LLC (AMKS TRL) following an inspection from June 17 to July 12, 2013, regarding their clinical investigation (Protocol (b)(4)) of the investigational drug (b)(4). The inspection, part of the Bioresearch Monitoring Program, identified significant violations of FDA regulations.

AMKS TRL failed to submit an Investigational New Drug (IND) application for (b)(4), which the FDA determined meets the definition of a drug due to its intended use in treating hepatitis C and HIV. The company's claim that (b)(4) was a dietary supplement was rejected. While AMKS TRL committed to not initiating further studies without FDA authorization, their July 30, 2013, response was deemed inadequate regarding monitoring and record-keeping.

Additionally, AMKS TRL failed to ensure proper monitoring of the investigation, lacking a written monitoring plan and failing to ensure the clinical investigator collected data on protocol-specific case report forms (CRFs). The provided CRF was also inconsistent with the protocol. Lastly, AMKS TRL did not maintain adequate records of the receipt, shipment, or disposition of the investigational drug, with their proposed SOP for future studies lacking sufficient detail or documentation.

AMKS TRL must address these deficiencies and establish procedures for future compliance. A written response detailing corrective actions is required within fifteen working days to avoid

Company
AMKS TIME RELEASE LAB, LLC
Inspection date
July 12, 2013
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Sean Y. Kassim (Deputy Office Director)
View Company Profile

ID · ba894059-cf4d-4059-9832-b7e9358461a0

Violation Codes10
21 U.S.C. 321(g)21 CFR 312.2(a)21 CFR 312.20(a)21 CFR 312.40(a)21 U.S.C. 35521 U.S.C. 355(i)21 CFR 312.4021 CFR 312.5021 CFR 312.56(a)21 CFR 312.57(a)

Full citation text and observation details available on the Dashboard.

Other documents for AMKS TIME RELEASE LAB, LLC
  • EIR - 2013-07-12July 12, 2013
  • 483 - 2013-07-12July 12, 2013
  • 483 - 2013-06-17June 17, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore AMKS TIME RELEASE LAB, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.